Peer Review Committee for Cancer Detection and Progression (CDP)
Areas Reviewed
Biomarker identification and pre-clinical development, including liquid biopsy and molecular imaging
Pre-clinical modeling to identify factors (such as microbiota, pathogens, nutrition, metabolism, oxygen levels, oncogenes, and tumor suppressor genes) and their mechanisms of action contributing to cancer progression
Mechanisms of therapeutic response, including tumor evolution and treatment resistance